卡帕菲克斯 (Kappaphycus alvarezii) 海藻对ZIKV的抗病毒活性
Caroline de S Barros1, Claudio C Cirne-Santos2, Priscilla O Esteves2,3
1Laboratório de Imunovirologia, Programa de Pós-graduação em Ciências e Biotecnologia, Programa de Pós-Graduação em Biotecnologia Marinha, Departamento de Imunobiologia, Instituto de Biologia, Universidade Federal Fluminense, Niterói, Brazil.
Current topics in medicinal chemistry
|May 27, 2024
概括
藻类Kappaphycus alvarezii显示强大的潜力对寨卡病毒 (ZIKV) 复制与低毒性. 这种天然提取物可能为开发抗ZIKV疗法提供新的途径.
科学领域:
- 海洋生物学 海洋生物学
- 病毒学 病毒学
- 自然产品化学 自然产品化学
背景情况:
- 寨卡病毒 (ZIKV) 是一种严重的公共卫生威胁,由Aedes蚊子传播,并导致严重的并发症,如小头症和吉兰-巴雷综合征 (GBS).
- 目前对ZIKV感染的治疗方法有限,需要探索新型治疗剂.
研究的目的:
- 评估海藻Kappaphycus alvarezii (K. alvarezii) 对寨卡病毒 (ZIKV) 复制的抗病毒潜力.
- 评估K. alvarezii提取物作为潜在的抗ZIKV化合物的安全性和作用机制.
主要方法:
- 使用Vero细胞进行细胞毒性测定,以确定CC50 (细胞毒性度中位数).
- ZIKV复制抑制试验用于确定EC50 (有效度中位数).
- 作用机制研究,包括病毒杀伤作用和与利巴维林的协同作用潜力.
主要成果:
- K. alvarezii提取物表现出低毒性 (CC50 = 423 μg/mL) 和强大的ZIKV抑制 (EC50 = 0.65 μg/mL),产生一个高的选择性指数 (SI = 651).
- 提取物表现出杀毒作用,可以延迟感染细胞的治疗,感染后长达6小时.
- 当K. alvarezii提取物与利巴维林结合时,观察到一个协同效应,达到99%的病毒复制抑制.
结论:
- 卡帕菲克斯 (Kappaphycus alvarezii) 提取物显示出显著的前景,作为一种安全有效的抗寨卡病毒药物.
- 需要进一步的研究来阐明K. alvarezii对ZIKV.的确切作用机制.
- 这项研究提出K. alvarezii提取物作为开发新型抗ZIKV治疗药物的潜在候选者.
相关概念视频
Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...


